Indogulf Cropsci Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 26 Aug 2026 | Fertilizers & Agrochemicals | Market Cap: ₹460 Cr
Indogulf Cropsciences expects continued growth in revenue and volumes, supported by strong performance in the past three quarters. Indogulf Cropsciences expects continued growth in revenue and profitability supported by both B2C and B2B segments, product expansion, and strengthened distribution.
From Indogulf Cropsci's Q3 FY26 earnings-call transcript · updated 26 Aug 2026.
Price
₹72.4
Market Cap
₹460 Cr
P/E Ratio
11.9
How does Indogulf Cropsci rank in Fertilizers & Agrochemicals?
Compare Indogulf Cropsci against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.
Indogulf Cropsci — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹109 Cr, net profit ₹4 Cr.
Full financials →📊 Revenue & Sales Performance
- →Indogulf Cropsciences expects continued growth in revenue and volumes, supported by strong performance in the past three quarters.
- →Quantitative volume growth in Q3 FY26 was slightly higher than value-wise growth due to a small price drop, indicating volume-led growth.
- →Expansion plans include new product launches scheduled mainly for Q1 and Q2 of the fiscal year, with four to five products shortlisted for upcoming launches.
- →Growth is expected from both B2C and B2B segments, with B2B showing robust increases.
- →Increased market penetration through expansion of Abhiprakash Globus Private Limited (AGPL) into more states, especially central India.
- →Entry into new international markets such as Venezuela, Taiwan, and Sudan is anticipated to support export revenue momentum.
- →Capacity expansion with a new plant at Barwasni is expected operational by end of Q1 FY27, aiding future growth.
- →Overall, management prefers letting performance speak instead of giving specific numeric guidance but remains optimistic about growth opportunities.
📈 Profitability & Margins
- →Indogulf Cropsciences expects continued growth in revenue and profitability supported by both B2C and B2B segments, product expansion, and strengthened distribution.
- →For FY26 and FY27, management refrains from giving specific numerical guidance but remains positive on growth opportunities across segments.
- →Growth drivers include new product launches (4-5 planned for Q1 FY27), capacity expansion (new plant operational by end Q1 FY27), and international market penetration.
- →Operating leverage and cost discipline have improved EBITDA margins, with expectation of better margins in coming quarters, though quarter-to-quarter volatility may persist.
- →Prior-period tax adjustments impacting Q3 FY26 PAT are one-time; steady-state tax rates anticipated going forward.
- →Expansion of Abhiprakash Globus Pvt Ltd (AGPL) and geographic reach, especially in central India and overseas markets, is expected to contribute to future growth.
- →Overall, the company emphasizes performance to demonstrate growth rather than providing forward-looking figures.
🏗️ Capital Expenditure Plans
- →Indogulf Cropsciences is undertaking capacity expansion with a new plant at Barwasni, expected to be operational by end of Q1 FY27, delayed by 2-3 months due to GRAP situation in Delhi NCR.
- →The infrastructure expansion aims to support growth in the coming years, especially enhancing B2C brand business with new product launches.
- →The company plans to expand the distribution network, particularly through Abhiprakash Globus Private Limited (AGPL), by entering additional states in central India and more overseas geographies.
- →Further overseas market expansions are planned following entry into Venezuela, Taiwan, and Sudan in the current year.
- →No specific revenue guidance from these expansions was given, but management expects growth driven by enhanced infrastructure, product basket diversification, and strategic execution.
- →These investments are aimed at scaling up operations and capturing growth opportunities created by patent expiries between 2024 and 2030 in the agrochemical sector.
💰 Fundraising & Capital Structure
- →There is no specific mention of any current or planned fundraising through debt or equity in the Q3 FY26 earnings call transcript.
- →The management did not provide any guidance or confirmation regarding raising capital via equity or debt.
- →Focus appears to be on internal growth strategies, capacity expansion (new plant at Barwasni), market expansion domestically and internationally, and product portfolio enhancement.
- →Capital expenditure is ongoing but funded through existing resources, with no explicit reference to external fundraising.
- →The company prefers to let performance speak rather than giving forward-looking financial commitments or funding plans.
📋 Order Book & Pipeline
- →Indogulf Cropsciences currently holds export orders from three countries: Venezuela, Taiwan, and Sudan.
- →The value of these export orders in hand is approximately INR 4 to 5 crores.
- →These orders are expected to be executed in Q4 FY26.
- →The company aims to leverage these orders to support export revenue momentum and improve capacity utilization in the quarter.
Key Metrics
Continue your research
What Indogulf Cropsci's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Rallis India (Q3 FY26)
Domestic B2C business growing steadily with 13% growth in Q3; volume expansion despite some price softness. Key concall takeaways from Rallis India's Q3 FY26…
- Sharda Cropchem (Q3 FY26)
Capex planned in the range of INR 450-500 crores to support growth and registration activities. Key concall takeaways from Sharda Cropchem Ltd's Q3 FY26…
- Krishana Phosch. (Q3 FY26)
It is noted that manufacturing is operating at almost 100% capacity and the company is importing to meet excess demand. Key concall takeaways from Krishana…
- Paradeep Phosph. (Q3 FY26)
Sustainable EBITDA per ton likely to improve by 30-35% once all sites achieve 100% backward integration (Page 13). Key concall takeaways from Paradeep…
Frequently Asked Questions
What were Indogulf Cropsci Q3 FY26 results?
Indogulf Cropsciences expects continued growth in revenue and volumes, supported by strong performance in the past three quarters. Indogulf Cropsciences expects continued growth in revenue and profitability supported by both B2C and B2B segments, product expansion, and strengthened distribution.
What is Indogulf Cropsci share price analysis?
Indogulf Cropsci currently shows a neutral. The stock trades at a P/E of 11.9 with a market cap of ₹460 Cr. Investors should review the full earnings analysis for detailed insights.
Is Indogulf Cropsci planning capital expenditure?
Indogulf Cropsciences is undertaking capacity expansion with a new plant at Barwasni, expected to be operational by end of Q1 FY27, delayed by 2-3 months due to GRAP situation in Delhi NCR.
Keep Indogulf Cropsci on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.